Risk and protective effects of the APOE gene towards Alzheimer’s disease in the Kungsholmen project: variation by age and sex

Background: The risk effect of APOE ε4 allele for Alzheimer’s disease is acknowledged, whereas the putative protective effect of ε2 allele remains in debate. Objectives: To investigate whether those inconsistent findings may be attributable to differences in age and sex composition of the study populations. Methods: A community dementia free cohort (n = 985) aged ⩾75 years was followed up to detect Alzheimer’s disease cases (DSM-III-R criteria). Data were analysed using Cox models with adjustment for major potential confounders. Results: Over a median 5.6 year follow up, Alzheimer’s disease was diagnosed in 206 subjects. Compared with APOE ε3/ε3 genotype, the relative risk (RR) of Alzheimer’s disease was 1.4 (95% confidence interval (CI), 1.0 to 2.0; p = 0.03) for heterozygous ε4 allele and 3.1 (95% CI, 1.6 to 5.9) for homozygous ε4 allele. The association between ε4 allele and Alzheimer’s disease risk was stronger in men than in women (RR related to the interaction term ε4 allele by sex, 0.4; 95% CI, 0.2 to 0.9). The ε4 allele accounted for one third of Alzheimer’s disease cases among men, but only one tenth among women. The ε2 allele was related to a reduced Alzheimer’s disease risk mainly in people aged <85 years (RR, 0.4; 95% CI, 0.2 to 0.8). The RR of Alzheimer’s disease related to the interaction term of ε2 allele by age was 2.4 (95% CI, 1.0 to 6.0; p = 0.06). Conclusions: The APOE genotype specific effects on Alzheimer’s disease vary by age and sex, in which the ε4 allele has a stronger risk effect in men, and the ε2 allele confers a protective effect only in younger-old people.

[1]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[2]  A. Hofman,et al.  Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. , 1998, Archives of neurology.

[3]  B. Winblad,et al.  Clinical diagnosis of Alzheimer's disease and other dementias in a population survey. Agreement and causes of disagreement in applying Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition, Criteria. , 1992, Archives of neurology.

[4]  David A. Bennett,et al.  The apolipoprotein E ε2 allele and decline in episodic memory , 2002 .

[5]  K. Welsh-Bohmer,et al.  APOE genotype predicts when — not whether — one is predisposed to develop Alzheimer disease , 1998, Nature Genetics.

[6]  E. Corder,et al.  Incidence of dementia in relation to stroke and the apolipoprotein E epsilon4 allele in the very old. Findings from a population-based longitudinal study. , 2000, Stroke.

[7]  A. Heald,et al.  Neurosyphilis presenting as complex partial status epilepticus. , 1996, European neurology.

[8]  B. Winblad,et al.  The influence of education on clinically diagnosed dementia incidence and mortality data from the Kungsholmen Project. , 2001, Archives of neurology.

[9]  N. Relkin,et al.  Apolipoprotein E genotyping in Alzheimer's disease , 1996, The Lancet.

[10]  E. L. Mortensen,et al.  A gender difference in the association between APOE genotype and age-related cognitive decline , 2001, Neurology.

[11]  D. Bennett,et al.  Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status. , 2003, Archives of neurology.

[12]  R. Frikke-Schmidt,et al.  APOE genotype predicts AD and other dementia but not ischemic cerebrovascular disease , 2001, Neurology.

[13]  P. Zandi,et al.  Incidence of AD may decline in the early 90s for men, later for women , 2002, Neurology.

[14]  J. Haines,et al.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.

[15]  B. Winblad,et al.  Occurrence of dementia in advanced age: the study design of the Kungsholmen Project. , 1992, Neuroepidemiology.

[16]  R. Sulkava,et al.  APOE ε4 does not predict mortality, cognitive decline, or dementia in the oldest old , 2000, Neurology.

[17]  R. Nussbaum,et al.  Alzheimer's disease and Parkinson's disease. , 2003, The New England journal of medicine.

[18]  S. DeKosky,et al.  Apolipoprotein E polymorphism and Alzheimer disease: The Indo-US Cross-National Dementia Study. , 2000, Archives of neurology.

[19]  Yaakov Stern,et al.  The APOE-∊4 Allele and the Risk of Alzheimer Disease Among African Americans, Whites, and Hispanics , 1998 .

[20]  A. Hofman,et al.  The apolipoprotein E ε2 allele is associated with an increased risk of early‐onset alzheimer's disease and a reduced survival , 1995 .

[21]  D. Galton,et al.  Apolipoprotein E genotyping in Alzheimer's disease. , 1996, Lancet.

[22]  G. Hathout,et al.  Mesiotemporal T2-weighted hyperintensity: neurosyphilis mimicking herpes encephalitis. , 2001, AJNR. American journal of neuroradiology.

[23]  J. Haines,et al.  Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .

[24]  A D Roses,et al.  Apolipoprotein E-epsilon 2 and Alzheimer's disease , 1997, Neurology.

[25]  R. Katzman.,et al.  Effects of apolipoprotein E on dementia and aging in the Shanghai Survey of Dementia , 1997, Neurology.

[26]  D. Easton,et al.  Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population , 2002, Journal of medical genetics.

[27]  D. Levy,et al.  Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study. , 2001, Atherosclerosis.

[28]  B. Winblad,et al.  Apolipoprotein E genotypes and the incidence of Alzheimer's disease among persons aged 75 years and older: variation by use of antihypertensive medication? , 2001, American journal of epidemiology.

[29]  E M Wijsman,et al.  Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. , 1996, American journal of human genetics.

[30]  M. Elia,et al.  Transient MRI abnormalities associated with partial status epilepticus: a case report. , 2001, European journal of radiology.

[31]  K Kontula,et al.  Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein. , 1995, The New England journal of medicine.

[32]  G. Maestre,et al.  Modulation by age and gender of risk for Alzheimer's disease and vascular dementia associated with the apolipoprotein E-ε4 allele in Latin Americans: findings from the Maracaibo Aging Study , 2001, Neuroscience Letters.

[33]  Arto Mannermaa,et al.  Apolipoprotein E 4 Allele, Elevated Midlife Total Cholesterol Level, and High Midlife Systolic Blood Pressure Are Independent Risk Factors for Late-Life Alzheimer Disease , 2002, Annals of Internal Medicine.

[34]  Jennifer L. Kelsey,et al.  Methods in Observational Epidemiology , 1986 .

[35]  B. Hyman,et al.  Apolipoprotein E and cognitive change in an elderly population , 1996, Annals of neurology.

[36]  C. Sing,et al.  The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, Minnesota. II. Regression relationships with concomitants. , 1992, American journal of human genetics.

[37]  J. Berger,et al.  Neurosyphilis in HIV-positive and HIV-negative patients: neuroimaging findings. , 1995, AJNR. American journal of neuroradiology.

[38]  K. Manton,et al.  Apolipoprotein E polymorphism and stroke in a population sample aged 75 years or more. , 1996, Stroke.

[39]  G. Schellenberg,et al.  Dementia and Alzheimer disease incidence: a prospective cohort study. , 2002, Archives of neurology.

[40]  J Tuomilehto,et al.  Midlife income, occupation, APOE status, and dementia: A population-based study , 2002, Neurology.

[41]  H. Braak,et al.  Gender and age modify the association between APOE and AD-related neuropathology , 2001, Neurology.

[42]  H. Soininen,et al.  Vascular risk factors, ApoE ϵ4 allele, and gender and the risk of Alzheimer's disease: perspectives on prevention , 2002 .

[43]  A. Hofman,et al.  Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study , 1997, The Lancet.

[44]  B. Winblad,et al.  Very Old Women at Highest Risk of Dementia and Alzheimer's Disease , 1997, Neurology.

[45]  D. Benson,et al.  Alzheimer's disease and Parkinson's disease , 1988, Neurology.